ISCO

International Stem Cell Corp.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 5/30/2017
Contact Info
  • 5950 Priestly Drive
  • Carlsbad, CA 92008

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0001355790
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2005
Employees 43 a/o May 30, 2017
Company Officers/Contacts
Andrey Semechkin CEO
Charles Casamento Administrator
Jennifer Stephens Acting CFO
Sophia Garnette VP, Legal, VP, Ops.
Russell Kern CSO, EVP
Investor Relations IR
Company Directors
Donald Wright Co-Chairman
Andrey Semechkin Co-Chairman
Charles Casamento
Paul V. Maier
Service Providers
Accounting/Auditing Firm
Mayer Hoffman McCann P.C.
2301 Dupont Drive
Suite 200
Irvine, CA, 92612
United States
 
Securities Counsel
DLA Piper
Livingston Place West
Suite 1000
250 2nd St. SW
Calgary, ALB, T2P 0C1
Canada
 
Investor Relations Firm

Not Available
Company History
  • Formerly=BTHC III, Inc. until 1-07
ISCO Security Details
Share Structure
Market Value1 $6,619,853 a/o Oct 20, 2017
Authorized Shares 120,000,000 a/o Mar 31, 2017
Outstanding Shares 4,012,032 a/o Aug 10, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.001
Shareholders
Shareholders of Record 9,100 a/o Mar 30, 2016
Short Selling Data
Short Interest 17,091 (-46.23%)
Sep 29, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security